How many times have you started to have a conversation with someone about Hepatitis C only to have it blow up in your face? Have you ever heard someone say something about Hep C that didn't seem quite right to you? You were probably right something was amiss. A discussion about Hepatitis C can...
As per Wikipedia, the definition of a stigma is as follows: "Stigma is a word that originally means a "sign", "point", or "branding mark"." Wikipedia goes on to call stigma "A badge of shame, a physical mark of infamy or disgrace." Damn that w...
Recently, the CDC (Center for Disease Control) issued a statement that all Baby Boomers should be tested for Hepatitis C. The question often comes up as to why this particular segment of people is so vulnerable. What does being born between 1945 and 1965 have to do with Hepatitis C? What was di...
Buyer Beware! There are several snake oil salesmen out there who are claiming to have cured their own Hepatitis C with herbs, supplements and parking lot gravel. Okay, maybe not the parking lot gravel but it might as well be. What you need to remember is that there are two different types of...
Most every adult woman (and an occasional man) has enjoyed a manicure and a pedicure at a nail salon or spa. That 30 minute pedicure can be so relaxing but are you aware of the danger lurking in that nail salon? Although few individuals recognize the medical risks associated with this common pr...

New Model to Simplify Applications and Make Funding More Predictable.
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria today voted to adopt a new approach to funding grants that will enable the organization to invest the world’s money more strategically and for greater impact.
The new funding model is designed to significantly improve grant-making, with a process that is more predictable and reliable, and also more flexible, so that it can achieve a higher success rate in all grants and more effectively save the lives of people affected by the three diseases.
“This is a tremendous, forward-looking change for the Global Fund,” said Simon Bland, Chair of the Board of the Global Fund. “In addition to the substantial amounts of money we are disbursing this year, this new funding model will make our grants even more effective in the future.”
Since late 2011, when the Board chose to re-focus its investments in a more strategic and targeted way, the Global Fund has performed a restructuring that concentrates 75 per cent of the staff in the core business of grant management, and reorganized the Grant Management Division in a way that improves the attention given to each country.
Now, the new funding model will change the way implementers apply for financing, get approval of their proposals and then manage their grants. Once fully developed, it will encourage national strategic plans in each country, and strive for more simplicity and efficiency.
Several aspects of the new funding model require further preparation, and the Board agreed to consider them at its next meeting in November.
One key element of the new system will be for applicants to submit a concept note, shorter than previous applications, and then get early feedback from the Global Fund, other donors and technical experts on how the proposal may need adjusting before moving forward. That is expected to reduce waiting times, and to improve the overall success rate of applications.
Another important change will be more flexible timing for grant applications: instead of having to apply at one set time, implementers will be able to better align the submission of grant proposals with their own national budgeting schedules.
“The Board has given us the principles, policies and definitions to implement the strategy of getting more value for money,” said Gabriel Jaramillo (see Report of the General Manager to the Board), General Manager of the Global Fund. “It's great to see the Board walk the talk. Now we can develop a new business model that will be simpler for implementers, will move resources faster to save lives, and will also give taxpayers in donor nations confidence that the Fund is responding to the times."
Under the new approach, countries will be grouped in bands, which will enable the Board to ensure focus is placed on countries with the highest disease burden and least ability to pay, among other factors.
The Board agreed that funds will be allocated to each band, and then divided in a way that identifies a range of funding for each country. In addition, the Board decided that a portion of funds would be used to provide incentives for ambitious requests based on specific investment cases and national strategies.
“Our common goal is to help as many people as we can by directing resources to areas of high disease burden and limited ability to pay,” said Sylvester Anemana, a board member representing West and Central Africa. “Making the process more effective means more lives are saved.”
Country Coordinating Mechanisms will continue to be the primary entity responsible in each country for submitting applications and overseeing grants. Each Country Coordinating Mechanism will engage with all stakeholders, including civil society, to develop robust applications to the Global Fund.
The new funding model will replace the rounds-based system, which was highly successful in the first years after the Global Fund was established in 2002 in spurring partnerships across sectors in many countries to identify and quantify their own needs in preventing and treating AIDS, TB and malaria.
However, the international financial crisis accelerated concerns that the Global Fund needed to invest for impact, and move away from a relatively passive role in shaping demand. The Board decided to make changes to ensure that it directs the organization’s investments toward those people most in need, and toward those interventions that can help the most people.
Consultations with partners, implementers, donors and other stakeholders in recent months yielded numerous suggestions on how to ensure that the new funding model adequately keeps the portfolio global, incentivizes well-performing programs and reinforces the principle of country-ownership. Many implementers also stressed the need to simplify and accelerate access to funding.
“This enables us to move forward with clear intentions,” said Rachel Ong, who represents the Communities delegation to the Board. “As a governance body, we are optimizing our direction and incentivizing demand, and that will help us raise the resources we need.”
In its decision, the Board agreed that the new model should enhance participation by all stakeholders, including civil society and will support continued funding for the needs of most-at-risk populations, so that concentrated epidemics are taken into consideration.
The Board also requested a regular evaluation of the new funding model, and asked the Board’s Strategy Investment and Impact Committee to continue working out the details of the funding model so that implementation can begin in 2013.
Please sign the ATC Salvage Therapy Petition Join us in asking Congressman Alcee Hastings and Congresswomen Maxine Waters to send a ‘Dear Colleague’ letter to Anthony Fauci, Director of NIAID, asking for the federal facilitation of apricitabine (ATC). ATC is a phase III nucleoside reverse transcriptase inhibitor (NRTI) that has been shown to be safe and effective in treating people with HIV. It works against viruses that are resistant to several other nukes and could ...
Researchers from Johns Hopkins Children’s Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School announced today at CROI2013 the discovery of the first infant functionally cured of HIV. The baby, a female now two and a half years old, received 3 HIV medications when brought to the hospital at 30 hours old. Viral load tests were performed during the first few weeks that showed a rapidly decreasing viral load which reached ...
At the 19th International AIDS Conference (AIDS 2012) in Washington D.C., the CDC reported that only 1 out of 4 HIV patients in the U.S. have HIV under control, which is defined as complete viral suppression. Warning bells should be ringing in the scientific and HIV advocacy communities. While much progress has been made in the last three decades in the treatment of HIV, tens of thousands of people living with HIV (PLWH) are currently struggling to construct viable treat...
Paige Rawl is 17 and HIV positive, but while her life has been shaped by HIV it isn't ruled by it. When Paige Rawl starts her senior year at Indianapolis’s Herron High School next month, she'll be cheer captain and a member of the student government and prom committee. This summer, the 17-year-old held down a part-time job at Hollister, hawking the popular Southern California-inspired clothing brand. The all-American girl — who happens to be HIV positive. Paige was in...
The HIV community has been abuzz with the August FDA approval of what had been termed “the Quad”, the second one-pill-once-a-day combination antiretroviral drug. Marketed by Gilead under the name Stribild, the drug contains two NRTIs (tenofovir and emtricitabine), an integrase inhibitor (elvitegravir) and an integrase booster (cobicistat) and is approved for use in treatment naïve patients with either drug resistant or wild type virus. In comparison to Atripla, the first...

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for SUSTIVA® (efavirenz), including dosing recommendations for...

California and other states would be pressured to amend or repeal criminal laws that single out HIV-positive people under a bipartisan bill co-authored and introduced this week by Rep. Barbara...
Mission Statement
At HIV Haven we wish to provide our readers with vital cutting edge information to help expand HIV knowledge and promote activism, particularly that which works towards an end to the HIV pandemic. It is our desire to bring to you the scientific, medical and social advances that given the appropriate attention and support, could change the course of the HIV pandemic, lessen the devastating effects of HIV and AIDS, better the quality and quantity of life for people living with HIV and even yield an eventual end to the HIV pandemic. We also provide the basics of HIV transmission and treatment.
We will focus on issues such as innovative drug development, strategic activist campaigns, HIV relationships and novel HIV and HIV cure research. We also will bring you advances in Hepatitis C (HCV), a common HIV co-infection. Whether you are living with HIV/AIDS, HIV and HCV, love someone who is, are an activist, advocate, researcher, physician or just an interested party, we hope here at HIV Haven we can help you find what you are looking for.